Advanced
Product
Solutions
Partners
Resources
Company
Toggle menu
Home
/
ORYX
ORYX
Overview
Locations
Financials
Operating Metrics
Human Capital
Key People
Competitors
Supplier Risk
ORYX
ORYX Summary
Company Summary
Overview
ORYX Translational Medicine is a company focusing on oncolytic virotherapy and cancer vaccines. It identifies, finances, and develops cancer immunotherapy projects.
Type
Private
Status
Active
Founded
2007
HQ
Vaterstetten, DE
|
view all locations
Website
http://oryx-medicine.com/
Cybersecurity rating
Sectors
Healthcare
biotech
oncology
Homepage
Linkedin
Table of Contents
Key People
Locations
Competitors
Key People
Bernard Huber,
Chief Executive Officer and Founder
Sven Rohmann,
Chief Business Development Officer
Michael Dahm,
Chief Medical Officer
Ottheinz Krebs,
Chief Operating Officer
Locations
View all
1 location detected
Vaterstetten, BY
HQ
Germany
Marktpl. 1
Competitors and Similar Companies
Innate Pharma
Healthcare - Public
A2 Biotherapeutics
Healthcare - Private
Vivia Biotech
Healthcare - Private
Scimega
Healthcare - Private
Compare competitors
Footer menu
Contact us
Product
Intelligence Suite
Supplier Intelligence Platform
Craft Intelligence Portal
Craft API
Craft for Teams
Supplier Intelligence Platform
Craft Alerts
Craft N-Tier Mapping
Craft Risk Hub
Chrome extension
Solutions
Supplier Intelligence
Sales Intelligence
Aerospace and Defense
Resources
Resource center
Blog
Company
About
Careers
Contact
Terms of Service
Privacy Policy
Security
© Craft.co 2026
Share price data provided by IEX
Back
to top